PTEN, a tumour suppressor, was downregulated in lung cancer and pancreatic ductal adenocarcinoma, enhancing the cancer invasiveness by NF-κB pathway transduction [29, 30]. This evidence concerns the gene NFKB1 and pancreatic ductal adenocarcinoma.